Volume 7 Supplement 2

Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2011

Open Access

Oral allergy syndrome and risk of food-related anaphylaxis: a cross-sectional survey analysis

  • Amanda Jagdis1,
  • Amin Kanani2 and
  • Donald Stark3
Allergy, Asthma & Clinical Immunology20117(Suppl 2):A2

DOI: 10.1186/1710-1492-7-S2-A2

Published: 14 November 2011

Background

Oral Allergy Syndrome (OAS) is an IgE-mediated allergic response to fresh fruits, nuts and vegetables caused by cross-reactivity between pollen allergens and structurally similar food proteins. Alder pollen is a prominent allergen in coastal British Columbia, present at high levels from February- April. We hypothesized that this exposure may lead to increased prevalence of Alder pollen allergy and OAS. We sought to determine our population-based prevalence, cross-reactivity patterns, and incidence of food-related anaphylaxis.

Methods

A chart review of 574 allergic rhinitis patients seen from January 2010 - June 2011 was performed. 274 OAS patients were invited to participate in an online, telephone or in-person survey. Patients completing the survey in the clinic were invited to undergo a panel of skin prick tests.

Results

63 patients were surveyed, 14 underwent skin testing. Patient characteristics included: median age=37 (range 20-77), 83% female, 36% atopic dermatitis, 24% asthma. OAS prevalence among seasonal allergic rhinitis patients=242/574 (42%). 14/14 patients were skin test positive for Alder and Birch. The most common OAS foods were apple 44/63 (70%), cherry 37/63 (59%), and peach 38/63 (60%). 28 had epinephrine auto-injector devices; 4 had used their device; 6/10 reactions involved foods that had caused OAS including apple, celery, green pepper, tomato, peanut, walnut.

Conclusions

In our population, the prevalence of OAS was slightly lower than expected at 42%. The most common OAS/pollen allergy was Alder, correlating with the high Alder pollen exposure in coastal British Columbia. OAS may be associated with serious reactions requiring use of epinephrine.

Authors’ Affiliations

(1)
Department of Internal Medicine, Faculty of Medicine, University of British Columbia
(2)
Division of Allergy and Immunology, Department of Internal Medicine, Faculty of Medicine, University of British Columbia
(3)
Division of Allergy and Immunology, Clinical associate professor, Department of Internal Medicine, Faculty of Medicine, University of British Columbia

Copyright

© Jagdis et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement